Tanner Smida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tanner Smida has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
James Bardes
Division of Prehospital Care, Department of Emergency Medicine, West Virginia University School of Medicine, Morgantown, WV
13 shared publicationsJames Scheidler
Department of Emergency Medicine, West Virginia University School of Medicine
11 shared publicationsP.S. Martin
West Virginia University Department of Emergency Medicine, Division of Prehospital Medicine, Morgantown, WV
7 shared publicationsRemle Crowe
ESO Solutions
7 shared publications- Remle P. Crowe
ESO Solutions
7 shared publications Bradley S. Price
John Chambers College of Business and Economics, West Virginia University
5 shared publications
Latest Publications
- 15 June 2026
- Published by Elsevier in Air Medical Journal
- Vol. 45 (5) , 477-483
A Retrospective Comparison of Etomidate and Ketamine for Prehospital Rapid Sequence Intubation
- 15 June 2026
- Published by Elsevier in Air Medical Journal
- Vol. 45 (5) , 477-483
A Retrospective Comparison of Etomidate and Ketamine for Prehospital Rapid Sequence Intubation
- 3 June 2026
- Published by Taylor & Francis in Prehospital Emergency Care
- p. 1-9
Prehospital Outcomes Associated with an Initial Strategy of Intranasal versus Intramuscular Naloxone Administration by EMS Clinicians: A Nationwide Cohort Study
INTRODUCTIONThe initial route used to administer naloxone to patients experiencing an opioid overdose in the prehospital setting by emergency medical services (EMS) clinicians may influence the eff...
- 3 June 2026
- Published by Taylor & Francis in Prehospital Emergency Care
- p. 1-9
Prehospital Outcomes Associated with an Initial Strategy of Intranasal versus Intramuscular Naloxone Administration by EMS Clinicians: A Nationwide Cohort Study
INTRODUCTIONThe initial route used to administer naloxone to patients experiencing an opioid overdose in the prehospital setting by emergency medical services (EMS) clinicians may influence the eff...
- 29 May 2026
- Published by Taylor & Francis in Prehospital Emergency Care
- Vol. 30 (8) , 1190-1197
Use of Double Sequential External Defibrillation in the United States Before and After the DOSE VF Randomized Clinical Trial
The Double Sequential External Defibrillation for Refractory Ventricular Fibrillation (DOSE VF) trial demonstrated improved outcomes for patients randomized to double sequential external defibrillation (DSED) in comparison to standard defibrillation, yet large-scale data on prehospital DSED use remain limited. We evaluated prehospital DSED use before and after publication of DOSE VF. We conducted a retrospective analysis of adult (>18 years of age) non-traumatic out-of-hospital cardiac arrest (OHCA) patients who had an initial rhythm of ventricular fibrillation or pulseless ventricular tachycardia and at least 4 successive defibrillation attempts in the ESO Data Collaborative from 2018-2024. We excluded patients with return of spontaneous circulation prior to the fourth defibrillation, resuscitation-limiting advanced directives, or OHCA due to drowning or overdose. To minimize the influence of agencies joining the Collaborative during the study period, we excluded agencies that did not contribute data during the first study year. We identified DSED using three methods: 1.) documentation of "Dual Sequence Defibrillation (DSD)", 2.) defibrillation at a 400J or 720J energy setting, or 3.) two defibrillations within 5 seconds. The DOSE VF trial was published in November 2022, and Q4 2022 was used as a washout period. We classified patients as treated pre-DOSE VF if treated before Q4 2022, and post-DOSE VF if treated after Q4 2022. We compared pre- and post-DOSE VF use of DSED using Pearson's 𝜒2 test and an interrupted time-series analysis using segmented Poisson regression with 3-month non-overlapping segments. We identified 16,450 DSED-eligible patients treated by 906 emergency medical services agencies. Estimates of DSED use varied by ascertainment method (Method 1: 3.7%, Method 2: 1.8%, Method 3: 4.4%, any method: 7.6%). The use of DSED detected by any method increased post-DOSE VF (pre vs. post: 822/11,228 (7.3%) vs. 381/4,625 (8.2%), p = 0.048). Segmented Poisson regression suggested an increase in the rate of DSED use (slope change) after DOSE VF (RR: 1.09 (1.04, 1.14) per quarter). Our findings suggest an increasing rate of DSED use after publication of DOSE VF, but the proportion of eligible patients receiving DSED remains low. Limitations include the potential for patient misclassification by our DSED ascertainment methods.
- 29 May 2026
- Published by Taylor & Francis in Prehospital Emergency Care
- Vol. 30 (8) , 1190-1197
Use of Double Sequential External Defibrillation in the United States Before and After the DOSE VF Randomized Clinical Trial
The Double Sequential External Defibrillation for Refractory Ventricular Fibrillation (DOSE VF) trial demonstrated improved outcomes for patients randomized to double sequential external defibrillation (DSED) in comparison to standard defibrillation, yet large-scale data on prehospital DSED use remain limited. We evaluated prehospital DSED use before and after publication of DOSE VF. We conducted a retrospective analysis of adult (>18 years of age) non-traumatic out-of-hospital cardiac arrest (OHCA) patients who had an initial rhythm of ventricular fibrillation or pulseless ventricular tachycardia and at least 4 successive defibrillation attempts in the ESO Data Collaborative from 2018-2024. We excluded patients with return of spontaneous circulation prior to the fourth defibrillation, resuscitation-limiting advanced directives, or OHCA due to drowning or overdose. To minimize the influence of agencies joining the Collaborative during the study period, we excluded agencies that did not contribute data during the first study year. We identified DSED using three methods: 1.) documentation of "Dual Sequence Defibrillation (DSD)", 2.) defibrillation at a 400J or 720J energy setting, or 3.) two defibrillations within 5 seconds. The DOSE VF trial was published in November 2022, and Q4 2022 was used as a washout period. We classified patients as treated pre-DOSE VF if treated before Q4 2022, and post-DOSE VF if treated after Q4 2022. We compared pre- and post-DOSE VF use of DSED using Pearson's 𝜒2 test and an interrupted time-series analysis using segmented Poisson regression with 3-month non-overlapping segments. We identified 16,450 DSED-eligible patients treated by 906 emergency medical services agencies. Estimates of DSED use varied by ascertainment method (Method 1: 3.7%, Method 2: 1.8%, Method 3: 4.4%, any method: 7.6%). The use of DSED detected by any method increased post-DOSE VF (pre vs. post: 822/11,228 (7.3%) vs. 381/4,625 (8.2%), p = 0.048). Segmented Poisson regression suggested an increase in the rate of DSED use (slope change) after DOSE VF (RR: 1.09 (1.04, 1.14) per quarter). Our findings suggest an increasing rate of DSED use after publication of DOSE VF, but the proportion of eligible patients receiving DSED remains low. Limitations include the potential for patient misclassification by our DSED ascertainment methods.
- 9 April 2026
- Published by Taylor & Francis in Prehospital Emergency Care
- Vol. 30 (8) , 1350-1357
Factors Associated with Successful Intravenous Access in the Prehospital Setting
INTRODUCTIONThe most common invasive procedure performed in the prehospital setting by emergency medical services (EMS) clinicians is intravenous (IV) cannula insertion, (1) but limited data exists...
- 9 April 2026
- Published by Taylor & Francis in Prehospital Emergency Care
- Vol. 30 (8) , 1350-1357
Factors Associated with Successful Intravenous Access in the Prehospital Setting
INTRODUCTIONThe most common invasive procedure performed in the prehospital setting by emergency medical services (EMS) clinicians is intravenous (IV) cannula insertion, (1) but limited data exists...
- 1 April 2026
- Published by Taylor & Francis in Prehospital Emergency Care
- p. 1-7
A ‘Target Trial Emulation’ of Prehospital Sublingual Nitroglycerin Administration for Suspected Acute Coronary Syndrome
Prehospital clinicians administer sublingual nitroglycerin to hundreds of thousands of patients per year in the United States for suspected acute coronary syndrome (ACS), but the effects of this intervention have not been thoroughly studied. We aimed to estimate the association between nitroglycerin administration and prehospital outcomes using a nationwide dataset. We evaluated all patients in the ESO Data Collaborative 2023 annual dataset with an EMS clinician primary impression that suggested chest pain, ACS, or a myocardial infarction who received 324 or 325 milligrams of aspirin from emergency medical services (EMS) clinicians following a 9-1-1 call for inclusion. We excluded patients who were th, 75th, and 90th percentile of follow-up time (17, 26, and 35 minutes). We analyzed 70,890 patients (34,887 (49%) nitroglycerin) from 2,119 EMS agencies. Overall, 139 (0.2%) patients experienced our composite outcome. Nitroglycerin administration was not associated with a significant decrease in the composite outcome at any timepoint following administration of aspirin overall (17 minutes: -0.02% (-0.08, +0.05); 26 minutes: -0.05% (-0.15, +0.06); 35 minutes: -0.10% (-0.30, +0.10)) or among the subgroup of patients with suspected STEMI. Nitroglycerin administration in the setting of suspected ACS was not associated with a reduction in our composite outcome in the prehospital setting. These analyses were limited by the low prevalence of our outcome and the retrospective, observational nature of these data.
- 1 April 2026
- Published by Taylor & Francis in Prehospital Emergency Care
- p. 1-7
A ‘Target Trial Emulation’ of Prehospital Sublingual Nitroglycerin Administration for Suspected Acute Coronary Syndrome
Prehospital clinicians administer sublingual nitroglycerin to hundreds of thousands of patients per year in the United States for suspected acute coronary syndrome (ACS), but the effects of this intervention have not been thoroughly studied. We aimed to estimate the association between nitroglycerin administration and prehospital outcomes using a nationwide dataset. We evaluated all patients in the ESO Data Collaborative 2023 annual dataset with an EMS clinician primary impression that suggested chest pain, ACS, or a myocardial infarction who received 324 or 325 milligrams of aspirin from emergency medical services (EMS) clinicians following a 9-1-1 call for inclusion. We excluded patients who were th, 75th, and 90th percentile of follow-up time (17, 26, and 35 minutes). We analyzed 70,890 patients (34,887 (49%) nitroglycerin) from 2,119 EMS agencies. Overall, 139 (0.2%) patients experienced our composite outcome. Nitroglycerin administration was not associated with a significant decrease in the composite outcome at any timepoint following administration of aspirin overall (17 minutes: -0.02% (-0.08, +0.05); 26 minutes: -0.05% (-0.15, +0.06); 35 minutes: -0.10% (-0.30, +0.10)) or among the subgroup of patients with suspected STEMI. Nitroglycerin administration in the setting of suspected ACS was not associated with a reduction in our composite outcome in the prehospital setting. These analyses were limited by the low prevalence of our outcome and the retrospective, observational nature of these data.
- 10 March 2026
- Published by Taylor & Francis in Prehospital Emergency Care
- Vol. 30 (8) , 1182-1189
A Retrospective Comparison of Plunger-Type and Band-Type Mechanical Chest Compression Devices for Prehospital Resuscitation
- 10 March 2026
- Published by Taylor & Francis in Prehospital Emergency Care
- Vol. 30 (8) , 1182-1189
A Retrospective Comparison of Plunger-Type and Band-Type Mechanical Chest Compression Devices for Prehospital Resuscitation
- 22 December 2025
- Published by Elsevier in Resuscitation
- Vol. 219, 110934
The prevalence of sustained electrical capture during prehospital transcutaneous pacing: a multicenter observational study
- 22 December 2025
- Published by Elsevier in Resuscitation
- Vol. 219, 110934
The prevalence of sustained electrical capture during prehospital transcutaneous pacing: a multicenter observational study
- 23 January 2025
- Published by Elsevier in Resuscitation
- Vol. 208, 110515
A retrospective ‘target trial emulation’ comparing amiodarone and lidocaine for adult out-of-hospital cardiac arrest resuscitation
- 23 January 2025
- Published by Elsevier in Resuscitation
- Vol. 208, 110515
A retrospective ‘target trial emulation’ comparing amiodarone and lidocaine for adult out-of-hospital cardiac arrest resuscitation
- 23 January 2025
- Published by Elsevier in Resuscitation
- Vol. 208, 110507
The association between initial defibrillation dose and outcomes following adult out-of-hospital cardiac arrest resuscitation: A retrospective, multi-agency study
- 23 January 2025
- Published by Elsevier in Resuscitation
- Vol. 208, 110507
The association between initial defibrillation dose and outcomes following adult out-of-hospital cardiac arrest resuscitation: A retrospective, multi-agency study